ELEVANCE HEALTH SECURITIES FRAUD NOTICE: Berger Montague Informs Elevance Health (NYSE: ELV) Investors of Securities Fraud Lawsuit

Core Viewpoint - A securities class action lawsuit has been filed against Elevance Health, Inc. for the period between April 18, 2024, and October 16, 2024, due to financial disclosures that negatively impacted the company's stock price [1][5]. Company Overview - Elevance Health, Inc. is a healthcare company based in Indianapolis, providing health insurance plans and administering Medicaid benefits for eligible beneficiaries [3]. Financial Disclosures - On July 17, 2024, Elevance announced an expected increase in Medicaid utilization, leading to a stock price decline of $32.21 per share, or 5.8%, closing at$ 520.93 [4]. - On October 17, 2024, Elevance reported Q3 2024 financial results, missing EPS expectations by $1.33, or 13.7%, due to elevated medical costs in its Medicaid business. The company also lowered its EPS guidance for 2024 from$ 37.20 to $33.00, or 11.3% [5]. - Following the October announcement, Elevance's stock price fell by$ 52.61 per share, or 10.6%, closing at $444.35 [6].